E-LIB Suche - Ergebnisse für: Ito, Mototsugu

1

A phase 1 randomized, placebo-controlled study to investiga..:

Ito, Mototsugu ; Walzer, Mark ; Blauwet, Mary Beth...
Journal of Psychopharmacology. 37 (2023) 5 - p. 449-461 , 2023

Link: https://doi.org/10.1177/..

2

A phase 1b study to investigate the potential interactions ..:

Ito, Mototsugu ; Walzer, Mark ; Beth Blauwet, Mary...
Journal of Psychopharmacology. 37 (2023) 2 - p. 144-154 , 2023

Link: https://doi.org/10.1177/..

3

Leveraging patient‐centric sampling for clinical drug devel..:

Maass, Katie F. ; Barfield, Matthew D. ; Ito, Mototsugu...
Clinical and Translational Science. 15 (2022) 12 - p. 2785-2795 , 2022

Link: https://doi.org/10.1111/..

4

A phase 1 study to assess potential interaction between ASP..:

Ito, Mototsugu ; Spence, Anna ; Blauwet, Mary Beth...
Journal of Psychopharmacology. 36 (2022) 6 - p. 756-767 , 2022

Link: https://doi.org/10.1177/..

5

Single‐ and multiple‐dose safety, tolerability, pharmacokin..:

Ito, Mototsugu ; Tauscher‐Wisniewski, Sitra ; Smulders, Ronald A....
Muscle & Nerve. 65 (2021) 1 - p. 110-120 , 2021

Link: https://doi.org/10.1002/..

6

Efficacy and safety of a 3-month dosing regimen of degareli..:

Ozono, Seiichiro ; Tsukamoto, Taiji ; Naito, Seiji...
Japanese Journal of Clinical Oncology. 47 (2017) 5 - p. 438-446 , 2017

Link: https://doi.org/10.1093/..

7

Pharmacokinetic Modeling and Monte Carlo Simulation to Pred..:

Ito, Mototsugu ; Kusuhara, Hiroyuki ; Ose, Atsushi...
The AAPS Journal. 19 (2016) 1 - p. 286-297 , 2016

Link: https://doi.org/10.1208/..

8

Evaluation of [11C]oseltamivir uptake into the brain during..:

Seki, Chie ; Oh-Nishi, Arata ; Nagai, Yuji...
EJNMMI Research. 4 (2014) 1 - p. , 2014

Link: https://doi.org/10.1186/..

9

Phosphorylated PKR contributes the induction of GRP94 under..:

Ito, Mototsugu ; Onuki, Reiko ; Bando, Yoshio..
Biochemical and Biophysical Research Communications. 360 (2007) 3 - p. 615-620 , 2007

Link: https://doi.org/10.1016/..

10

Leveraging patient‐centric sampling for clinical drug devel..:

Maass, Katie F ; Barfield, Matthew D ; Ito, Mototsugu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747123/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Single‐ and multiple‐dose safety, tolerability, pharmacokin..:

Ito, Mototsugu ; Tauscher‐Wisniewski, Sitra ; Smulders, Ronald A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298414/. , 2021

Link: http://www.ncbi.nlm.nih...

12

Efficacy and safety of a 3-month dosing regimen of degareli..:

Ozono, Seiichiro ; Tsukamoto, Taiji ; Naito, Seiji...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421626/. , 2017

Link: http://www.ncbi.nlm.nih...

13

Evaluation of [11C]oseltamivir uptake into the brain during..:

Seki, Chie ; Oh-Nishi, Arata ; Nagai, Yuji...
http://www.ejnmmires.com/content/4/1/24. , 2014

Link: http://www.ejnmmires.com..

14

Leveraging patient‐centric sampling for clinical drug devel..:

Katie F. Maass ; Matthew D. Barfield ; Mototsugu Ito...
https://doi.org/10.1111/cts.13411. , 2022

Link: https://doi.org/10.1111/..

15

Impact of timing and initial recurrence site on post-recurr..:

Akamine, Takaki ; Takenaka, Tomoyoshi ; Yano, Tokujiro...
European Journal of Surgical Oncology. , 2024

Link: https://doi.org/10.1016/..